Low expression of LncRNA-CAF attributed to the high expression of HIF1A in esophageal squamous cell carcinoma and gastric cancer patients

• Published in: Molecular biology reports 2022-02, Vol.49 (2), p.895-905
• Main Authors: Bahramian, Shabbou, Sahebi, Reza, Roohinejad, Zahra, Delshad, Encieh, Javid, Naeme, Amini, Abolfazl, Razavi, Amirnader Emami, Shafiee, Mohammad, Shamsabadi, Fatemeh T.
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animal Anatomy; Animal Biochemistry; Apoptosis; Apoptosis - genetics; Biomarkers, Tumor - genetics; Biomedical and Life Sciences; Cancer-Associated Fibroblasts - metabolism; Carcinoma, Squamous Cell - genetics; Cell Line, Tumor; Cell Proliferation - genetics; Esophageal cancer; Esophageal Neoplasms - genetics; Esophageal Squamous Cell Carcinoma - genetics; Esophageal Squamous Cell Carcinoma - metabolism; Esophagus; Fibroblasts; Gastric cancer; Gene Expression - genetics; Gene Expression Regulation, Neoplastic - genetics; Gene therapy; Histology; Humans; Hypoxia-Inducible Factor 1, alpha Subunit - genetics; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism; Life Sciences; Metastases; Morphology; Myc protein; Non-coding RNA; Original Article; Patients; Peroxisome proliferator-activated receptors; Proteins; RNA, Long Noncoding - genetics; Squamous cell carcinoma; Stat1 protein; Stomach Neoplasms - genetics; Stomach Neoplasms - metabolism; Tumor microenvironment; Tumor Microenvironment - genetics; Tumors; Vascular endothelial growth factor
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-021-06882-0

Purpose Cancer-associated fibroblasts (CAFs) are major components of tumor microenvironment that stimulate ESCC and GC progression. The LncRNA-CAF, FLJ22447, is located in the vicinity of HIF1A, while their association remains unclear. This study aims to assess the FLJ22447 expression in the ESCC and GC patients and evaluate its association with the HIF1A gene. Methods Fresh ESCC and GC tumor samples and their adjacent non-tumor tissues were collected from patients who underwent surgery in Imam Khomeini Hospital, Tehran, Iran. The expression of FLJ22447, HIF1A, and VEGF was evaluated using qRT-PCR test. The association of their expression with tumor clinicopathological features in ESCC patients was assessed. System biology tools were then applied for the possible biological subsequences of the FLJ22447. Results A significant reduction in FLJ22447 expression was observed in ESCC and GC tissues than adjacent non-tumor tissues, while, the expression of HIF1A and VEGF were increased. Low expression of FLJ22447 was significantly correlated with HIF1A ( P  = 2.4e–73, R = 0.63) and VEGF ( P  = 0.00019, R = 0.15) expression. A significant relationship was detected between the high expression of HIF1A and tumor stages (I–II) and it was related to the reduced survival of ESCC patients. Conversely, increased VEGF expression was linked to the advanced stages (III–IV) and metastasis in ESCC. The analysis of FLJ22447-interacted proteins showed that MYC, JUN, SMRCA4, PPARG, AR, FOS, and CEBPA are the hub genes. These proteins were implicated in the cancer related pathways. Among them, SPI1, E2F1, TCF7L2, and STAT1 were significantly expressed in esophageal and gastric cancers that were functionally involved in the proliferation, apoptosis, and angiogenesis pathways in cancer. Conclusion The results suggested that FLJ22447 may have a regulatory function on the HIF1A expression. We identified the FLJ22447-interacted proteins and their molecular function in cancer pathogenesis. Further research emphasis is to realize the association of FLJ22447 with its protein partners in progression of cancer. These may provide an insight into the FLJ22447 activity that could introduce it as a potential value in tumor gene therapy.